Home > Healthcare > Biotechnology > Biotechnology R&D > Mice Model Market
Mice Model Market size exceeded USD 9.5 billion in 2022 and will depict over 6% CAGR from 2023 to 2032, driven by rising demand for humanized mice models.
The genetic resemblance between mice and humans is positively influencing market growth and boosting the demand for mouse models in biomedical research. The positive inclination of researchers toward the study of human diseases using mouse models as humans share more than 95% of their protein-coding and over 28% of non-coding sequences with mice genome, is set to provide lucrative opportunities to the market.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Mice Model Market Size in 2022: | USD 9.5 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 6% |
2032 Value Projection: | USD 18 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 366 |
Tables, Charts & Figures: | 773 |
Segments covered: | Mice, Technology, Application, Use, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Despite a positive outlook for the mice model market, ongoing developments of alternative methods for animal testing will negatively influence product adoption. Researchers are compelled to find strategies to save time and employ fewer animals in drug screening procedures since millions of experimental animals are utilized each year globally. Scientists have therefore devised other methods that would reduce the number of mice employed as research subjects. Nonetheless, promising developments in the field would aid in overcoming this issue.